share_log
Moomoo 24/7 ·  Apr 3 08:10
Alto Neuroscience Has Initiated Phase 2 Study Of ALTO-203 In Major Depressive Disorder; Alto Expects To Report Topline Data From This Study In 1H Of 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment